Accumulated experience with prenatal diagnosis of Menkes disease by neutron activation analysis of chorionic villi specimens.
Since 1983, prenatal diagnosis of Menkes disease has been carried out by determining Cu in samples of chorionic villi from the fetus by means of radiochemical neutron activation analysis. Concentrations of Cu in chorionic villi from male fetuses later confirmed to have Menkes disease were invariably higher than previously reported values for normal controls. Out of 240 samples analyzed in the period 1983-1998, there were 71 from female fetuses that could be carriers of the Menkes genetic defect without suffering from the disease. Increased concentrations of Cu in these samples could not be attributed to the presence of this genetic defect, but might result from sporadic contamination of the samples before analysis. Such contamination also may occur in samples from male fetuses and thus raise the level of Cu in small, but normal specimens into the range characteristic of Menkes disease. In spite of a strict protocol for taking samples without contamination, a total of four false positives were reported during the period of investigation; no false negatives have occurred.
Heydorn
K
K
Isotope Division, Risø National Laboratory, Roskilde, Denmark.
Damsgaard
E
E
Horn
N
N
D015193:Chorionic Villi Sampling; D003300:Copper / Q000032:analysis; D005260:Female; D006580:Genetic Carrier Screening; D006801:Humans; D008297:Male; D007706:Menkes Kinky Hair Syndrome / Q000175:diagnosis* / Q000235:genetics; D009501:Neutron Activation Analysis; D011296:Prenatal Diagnosis; D012680:Sensitivity and Specificity
D003300:Copper